OnKure Therapeutics (OKUR) Current Leases (2022 - 2026)
OnKure Therapeutics' (OKUR) quarterly Current Leases came in at $409000.0 in Q1 2026, down 25.09% YoY from $546000.0 in Q1 2025, and down 25.5% on a QoQ basis from $549000.0 in Q4 2025.
OnKure Therapeutics (OKUR) Current Leases (2022 - 2026) Analysis & Trends
OnKure Therapeutics (OKUR) has 5 years of Current Leases data on file, last reported at $409000.0 in Q1 2026.
- Quarterly Current Leases fell 25.09% year-over-year to $409000.0 in Q1 2026, while the trailing twelve-month figure through Mar 2026 was $409000.0 (down 25.09% YoY) and the FY2025 annual result came in at $549000.0, up 2.43% from the prior year.
- Current Leases eased to $409000.0 in Q1 2026, from $549000.0 in the prior quarter.
- In the past five years, Current Leases ranged from a high of $567000.0 in Q3 2025 to a low of $208000.0 in Q4 2023.
- A 5-year average of $412000.0 and a median of $408000.0 in 2022 frame the typical range for Current Leases.
- Annual changes were most pronounced in 2023 — Current Leases sank 48.51% — and 2024, when it soared 157.69%.
- Tracing OKUR's Current Leases over 5 years: stood at $404000.0 in 2022, then slumped by 48.51% to $208000.0 in 2023, then soared by 157.69% to $536000.0 in 2024, then gained by 2.43% to $549000.0 in 2025, then dropped by 25.5% to $409000.0 in 2026.
- The last three Current Leases figures came in at $409000.0 (Q1 2026), $549000.0 (Q4 2025), and $567000.0 (Q3 2025), per Business Quant data.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Current Leases (Qtr) |
|---|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 137.11 Bn | 129.26 Bn | 2.84 Bn | - |
| 2 | Regeneron Pharmaceuticals | 84.98 Bn | 76.99 Bn | 3.93 Bn | 720.00 Mn |
| 3 | Argenx Se | 64.52 Bn | 59.33 Bn | 1.37 Bn | - |
| 4 | Moderna | 53.23 Bn | 48.09 Bn | 52.00 Mn | - |
| 5 | BeOne Medicines | 41.23 Bn | 36.14 Bn | 1.53 Bn | 21.95 Mn |
| 6 | Alnylam Pharmaceuticals | 30.65 Bn | 27.34 Bn | 992.69 Mn | 45.93 Mn |
| 7 | Insmed | 27.15 Bn | 25.99 Bn | 358.27 Mn | 6.27 Mn |
| 8 | Royalty Pharma | 26.98 Bn | 26.14 Bn | - | - |
| 9 | BioNTech SE | 26.78 Bn | 8.39 Bn | 668.28 Mn | - |
| 10 | OnKure Therapeutics | 196.98 Mn | 20.60 Mn | - | 336,000.00 |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | 336,000.00 |
| Mar 31, 2026 | 409,000.00 |
| Dec 31, 2025 | 549,000.00 |
| Sep 30, 2025 | 567,000.00 |
| Jun 30, 2025 | 556,000.00 |
| Mar 31, 2025 | 546,000.00 |
| Dec 31, 2024 | 536,000.00 |
| Sep 30, 2024 | 286,000.00 |
| Jun 30, 2024 | 331,000.00 |
| Mar 31, 2024 | 331,000.00 |
| Dec 31, 2023 | 208,000.00 |
| Sep 30, 2023 | 325,000.00 |
| Jun 30, 2023 | 318,000.00 |
| Mar 31, 2023 | 363,000.00 |
| Dec 31, 2022 | 404,000.00 |
| Sep 30, 2022 | 410,000.00 |
| Jun 30, 2022 | 408,000.00 |
| Mar 31, 2022 | 457,000.00 |